Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.98 USD | -1.16% | -3.37% | -15.08% |
Apr. 22 | Leerink Partners Adjusts Price Target on CVS Health to $87 From $88 | MT |
Apr. 17 | CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs |
Financials (USD)
Sales 2024 * | 371B | Sales 2025 * | 393B | Capitalization | 85.42B |
---|---|---|---|---|---|
Net income 2024 * | 8.84B | Net income 2025 * | 9.86B | EV / Sales 2024 * | 0.36 x |
Net Debt 2024 * | 48.01B | Net Debt 2025 * | 43.34B | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
9.86
x | P/E ratio 2025 * |
8.74
x | Employees | 259,500 |
Yield 2024 * |
3.9% | Yield 2025 * |
4.15% | Free-Float | 72.34% |
Latest transcript on CVS Health Corporation
1 day | -0.19% | ||
1 week | -1.21% | ||
Current month | -15.03% | ||
1 month | -13.65% | ||
3 months | -8.65% | ||
6 months | -1.74% | ||
Current year | -14.17% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
David Falkowski
CMP | Compliance Officer | - | 11-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 18 M€ | +3.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 67.02 | -1.10% | 2 372 348 |
24-04-24 | 67.77 | -1.07% | 8,651,960 |
24-04-23 | 68.5 | -1.62% | 8,450,704 |
24-04-22 | 69.63 | -0.17% | 5,701,582 |
24-04-19 | 69.75 | +0.52% | 7,809,721 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.17% | 85.42B | |
+17.86% | 84.38B | |
+10.92% | 29.39B | |
-8.51% | 17.49B | |
-2.32% | 16.44B | |
-0.24% | 15.28B | |
+0.71% | 12.22B | |
-31.23% | 11.98B | |
-2.92% | 11.71B | |
+26.71% | 11.64B |
- Stock Market
- Equities
- CVS Stock